Geneva Young

发表

A High Frequency of Activating Extracellular Domain ERBB2 (HER2) Mutation in Micropapillary Urothelial Carcinoma

Kai Wang, Timothy A Jennings, Doron Lipson, 2013, Clinical Cancer Research.

LYMPHOID NEOPLASIA Integrated genomic DNA/RNA pro ﬁ ling of hematologic malignancies in the clinical setting

Alex M. Fichtenholtz, S. Armstrong, P. Stephens, 2016 .

Analytical Validation of a Hybrid Capture–Based Next-Generation Sequencing Clinical Assay for Genomic Profiling of Cell-Free Circulating Tumor DNA

Doron Lipson, Bernard Fendler, Jeffrey P. Gregg, 2018, The Journal of molecular diagnostics : JMD.

Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting.

Alex M. Fichtenholtz, S. Armstrong, P. Stephens, 2016, Blood.

Profiling Genomic Alterations Of Diffuse Large B-Cell Lymphoma (DLBCL) At Diagnosis, Relapse, and Transformation, Using a Novel Clinical Diagnostic Targeted Sequencing Platform

A. Zelenetz, P. Stephens, R. Yelensky, 2013 .

Identification Of Actionable Genomic Alterations In Hematologic Malignancies By a Clinical Next Generation Sequencing-Based Assay

Alex M. Fichtenholtz, S. Armstrong, P. Stephens, 2013 .

Clinical next‐generation sequencing successfully applied to fine‐needle aspirations of pulmonary and pancreatic neoplasms

P. Stephens, R. Yelensky, D. Lipson, 2013, Cancer cytopathology.

Analytic validation of a clinical circulating tumor DNA assay for patients with solid tumors

T. Clark, D. Lipson, V. Miller, 2016 .

Abstract 3965: Rigorous validation of a clinical circulating tumor DNA assay for cancer molecular profiling

T. Clark, D. Lipson, G. Otto, 2016 .

Analytic validation of a clinical circulating tumor DNA assay for patients with solid tumors.

T. Clark, D. Lipson, V. Miller, 2016 .